Uterine fibroids and Black people of African descent globally: a scoping review protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
25 Aug 2024
Historique:
medline: 26 8 2024
pubmed: 26 8 2024
entrez: 25 8 2024
Statut: epublish

Résumé

Evidence suggests that when adjusted for age and other factors such as Body Mass Index, age of first pregnancy, years since last pregnancy and alcohol consumption, Black women are three times more likely to suffer from fibroids compared with the general population. When compared with the general population, Black women experience larger uterine fibroids with an earlier onset and more frequent and severe symptoms debilitating symptoms. Reported symptoms include pelvic pain, bladder issues, and heavy and/or abnormal menstrual bleeding. For Black women in perimenopause or menopause, uterine fibroids are more likely to continue growing rather than slow or cease. To design empirical research that addresses the issue of uterine fibroids among Black people of African descent, it is important to understand the current state of literature on this issue. The objectives of this scoping review are to understand and describe the extent and type of literature available regarding Black people of African descent with uterine fibroids globally, to identify the gaps within existing literature, and to provide recommendations for future research. This scoping review will be conducted in accordance with JBI scoping review methodology and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews Checklist. Eligibility criteria for this review include sources that involve Black people of African descent who have uterine fibroids. This review is global in context and does not include jurisdictional, geographical, regional or study setting restrictions. A comprehensive search strategy developed in collaboration with a health sciences librarian will be used to identify and retrieve relevant peer-reviewed and grey literature. Databases including CINAHL (EBSCO), MEDLINE (Ovid), Embase (Elsevier), Gender Studies Database (EBSCO), Scopus (Elsevier) and LILACS (VHL) will be searched from inception to January 2024. Unpublished studies and grey literature searches will include The Society for Women's Health Research, Black Women's Health Imperative, ProQuest Dissertations and Theses Global (ProQuest), Open Access Theses and Dissertations (OATD.org) and Google search. All relevant sources will be uploaded to Covidence and undergo title and abstract screening by two independent team members. Selected sources will then undergo full-text review by two independent team members. Sources meeting the eligibility criteria will undergo extraction by two independent team members. Thematic analysis will be used to classify the extracted data points into categories according to the purpose or objective of the source, the methods used, the geographical region or jurisdiction of the source, key findings and recommendations. The synthesis of results will align with the review objective and question using charts or tables where necessary. This scoping review does not require ethical approval. Dissemination of the review results includes the publication of a full report in a peer-reviewed journal as well as presenting the review results at local, national and international conferences. The results of the scoping review will also be disseminated through community events and social media using infographics and brochures.

Identifiants

pubmed: 39182930
pii: bmjopen-2024-085622
doi: 10.1136/bmjopen-2024-085622
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e085622

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Keisha Jefferies (K)

School of Nursing, Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada Keisha.Jefferies@dal.ca.

Lisa Bland (L)

School of Nursing, Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada.

Bukola Oladimeji (B)

School of Nursing, Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada.

Melissa Rothfus (M)

W.K. Kellogg Health Sciences Library, Dalhousie University, Halifax, Nova Scotia, Canada.

Josephine Etowa (J)

School of Nursing, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada.

Angela Alleyne (A)

Department of Biological and Chemical Sciences, Faculty of Science and Technology, The University of the West Indies Cave Hill Campus, Bridgetown, Saint Michael, Barbados.

Bukola Salami (B)

Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Shane Austin (S)

Department of Biological and Chemical Sciences, Faculty of Science and Technology, The University of the West Indies Cave Hill Campus, Bridgetown, Saint Michael, Barbados.

Megan Aston (M)

School of Nursing, Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada.

Emma Stirling-Cameron (E)

School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH